MyAverix Finance
HK · Healthcare
United Laboratories International Holdings Ltd (3933)
Drug Manufacturers - Specialty & Generic
United Laboratories International Holdings Ltd (3933) is listed on HK in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-21, reported market cap is $17.44B, P/E ratio is 6.96, net margin is 15.8%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 3933
United Laboratories International Holdings Ltd (3933) — FAQ
What is United Laboratories International Holdings Ltd's market cap?
United Laboratories International Holdings Ltd (3933) has a reported market cap of $17.44B (data as of 2026-05-21).
What is 3933's P/E ratio?
The price-to-earnings (P/E) ratio for United Laboratories International Holdings Ltd (3933) is 6.96 (data as of 2026-05-21).
Does United Laboratories International Holdings Ltd pay a dividend?
Dividend yield is not available in the current snapshot for United Laboratories International Holdings Ltd (3933). Check the MyAverix Finance app for the latest dividend data.
What sector is United Laboratories International Holdings Ltd in?
United Laboratories International Holdings Ltd (3933) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 3933 listed on?
3933 is listed on HK.
What is United Laboratories International Holdings Ltd's net margin?
United Laboratories International Holdings Ltd (3933) reports a net margin of 15.8% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.